New influenza vaccine strategies aim to enhance protection with T-cell responses

FHS
May 6, 2024
4:13 am

A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.

Opinion | ‘Curable’: A Case for Precision of Language

Casey is a physician assistant. In the movie The Giver, the young protagonist Jonas asks a poignant question: “Father, do you love me?” His mother

December 20, 2023

Health care execs mostly donate to Democrats, but avoid Trump and Harris

A vast majority of CEOs of major health systems and insurers are steering clear of donating their money to either Vice President Harris or former

November 1, 2024

Sarepta’s Elevidys secures US label expansion for DMD – Pharmaceutical Technology

Elevidys uses a recombinant adeno-associated virus vector serotype 74 (AAV74) to deliver a dystrophin encoding microdystrophin transgene. Credits: T. Schneider/Shutterstock.com Just a week after Pfizer

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.